Professor at Nantong University School of Medicine, China
Professor Wenqing Li is a distinguished scientist in the field of biomedical science, currently serving as a professor at the School of Medicine, Nantong University. He holds a B.S. in Biological Sciences from Anhui Normal University (2009) and a Ph.D. in Cell Biology from the University of Science and Technology of China (2014). His postdoctoral training was conducted at The Pennsylvania State University (2014–2016), followed by a research position at The Ohio State University (2016–2020). Since 2020, he has led an innovative research program at Nantong University, contributing significantly to the fields of nanomedicine, cancer immunotherapy, and male reproductive health.
profile
scopus
Education
Dr. Li’s academic journey is rooted in top-tier Chinese and American institutions. He began with a Bachelor’s degree in Biological Sciences at Anhui Normal University, developing a strong foundation in molecular biology. His passion for advanced cellular mechanisms led him to pursue a Ph.D. in Cell Biology at the prestigious University of Science and Technology of China, where he cultivated expertise in nanobiotechnology. Further enhancing his academic experience, he undertook rigorous postdoctoral research at The Pennsylvania State University, followed by a role as assistant researcher at The Ohio State University. These global experiences shaped his multidisciplinary approach to research in biomedicine.
Experience
Dr. Li’s professional experience spans academia and international research environments. His early postdoctoral work at Penn State focused on nanomaterials and bio-conjugates. At Ohio State, he contributed to translational nanomedicine, developing innovative drug delivery systems. His current role as professor at Nantong University involves supervising research in lipid nanoparticle-based therapeutics, immunotherapy, and reproductive biology. A recognized research leader, he is also a key member of the Jiangsu Provincial Outstanding Scientific and Technological Innovation Team for Male Reproductive Health and has successfully secured and led major grants from the National Natural Science Foundation of China.
Research Interest
Professor Li’s research interests lie at the intersection of nanotechnology, molecular biology, and immunotherapy. His current work centers on the development of lipid nanoparticles for mRNA delivery and cancer immunotherapy, including platforms co-delivering STING agonists and mRNA to synergize antitumor responses. He also investigates lipid nanoparticle applications in restoring spermatogenesis in infertile males and treats Non-Obstructive Azoospermia (NOA). His broad interests also include nanotoxicology and male contraceptive development using functionalized nanomaterials. His translational research has bridged fundamental science with therapeutic innovations.
Award
Professor Li was honored with the Jiangsu Distinguished Professor Award in 2020 in recognition of his contributions to biomedical science and innovation. He was also the recipient of funding from the National Natural Science Foundation of China (Youth Program) between 2016 and 2018 for his work on the reproductive toxicity of gold nanoparticles. His innovative research and leadership in translational nanomedicine have garnered national attention, positioning him as a strong contender for the Best Researcher Award.
Publication
Among his numerous high-impact publications, seven notable articles include:
“Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis” published in Nature Nanotechnology (2020), cited 226 times.
“Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing” published in Science Advances (2020), cited 144 times.
“Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo” in Advanced Materials (2020), cited 106 times.
“Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy” in Nature Communications (2021), cited 82 times.
“Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice” in Chemical Science (2018), cited 99 times.
“Long-term storage of lipid-like nanoparticles for mRNA delivery” in Bioactive Materials (2020), cited 183 times.
“Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination” in ACS Applied Materials & Interfaces (2025), early-stage with growing recognition.
These publications have significantly influenced nanomedicine, genome editing, and therapeutic delivery systems.
Conclusion
In conclusion, Dr. Wenqing Li exemplifies the qualities of an outstanding researcher. His academic rigor, innovation in lipid-based nanotechnology, impactful publications, and translational focus collectively position him as a leading figure in biomedical science. His contributions not only push the boundaries of current knowledge but also pave the way for novel therapeutic approaches. Therefore, it is with strong confidence that Dr. Wenqing Li is recommended as a highly deserving recipient of the Best Researcher Award.